4
Changes in Ownership
RESMED INC Filed Acc 0001127602-22-025860
Chief Executive Officer sold 5,675 shares at $224.64 ($1,274,837)
- Chief Executive Officer acquired 5,675 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farrell Michael J. Chief Executive Officer | 2022-11-15 | Option exercise | +5,675 | $57.76 | $327,788 | 419,699 | D: show line 1 in the form |
| Farrell Michael J. Chief Executive Officer | 2022-11-15 | Sale | −5,675 | $224.64 | $1,274,837 | 414,024 | D: show line 2 in the form |
| Open-market sales · 5,675 sh · avg $224.64 · $1,274,837 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farrell Michael J. Chief Executive Officer | 2022-11-15 | Option exercise · ResMed Common Stock Options | −5,675 | 71,565 | D: show line 3 in the form |
Loading xslF345X03/form4.xml…